Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy (Q38880569)

7 September 2017

1 reference

title

Ten Emerging Trends in the Epidemiology of Diabetic Retinopathy (English)

1 reference

7 September 2017

1 reference

Charumathi Sabanayagam

1

1 reference

7 September 2017

WanFen Yip

2

1 reference

7 September 2017

Daniel S W Ting

3

1 reference

7 September 2017

Gavin Tan

4

1 reference

7 September 2017

Tien Y Wong

5

1 reference

7 September 2017

29 June 2016

1 reference

7 September 2017

Ophthalmic Epidemiology

1 reference

7 September 2017

23

1 reference

7 September 2017

209-222

1 reference

7 September 2017

4

1 reference

Global estimates of diabetes prevalence for 2013 and projections for 2035.

7 September 2017

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Epidemiology of diabetic retinopathy and maculopathy in Africa: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Screening and public health strategies for diabetic retinopathy in the Eastern Mediterranean region

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Are individuals with diabetes seeing better?: a long-term epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Global prevalence and major risk factors of diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Management paradigms for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Diabetic retinopathy screening: a systematic review of the economic evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Long-term Comparative Effectiveness of Telemedicine in Providing Diabetic Retinopathy Screening Examinations: A Randomized Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Optical coherence tomography--current and future applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Diabetic retinopathy screening and the use of telemedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Anti-vascular endothelial growth factor therapy for diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Novel Therapies in Development for Diabetic Macular Edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Global estimates of the prevalence of diabetes for 2010 and 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Rising prevalence of diabetes: evidence from a Danish pharmaco-epidemiological database

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes-the Linköping Diabetes Complications Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Temporal trends in the age-specific prevalence of diabetes and diabetic retinopathy in older persons: Population-based survey findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Rates of progression in diabetic retinopathy during different time periods: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effectiveness of screening in preventing blindness due to diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Globalization of diabetes: the role of diet, lifestyle, and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Hypertension in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Emerging epidemic of cardiovascular disease in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Prevalence of diabetic retinopathy in the United States, 2005-2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Four-year incidence and progression of diabetic retinopathy and macular edema: the Los Angeles Latino Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Current epidemiology of diabetic retinopathy and diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Incidence of retinal complications in a cohort of newly diagnosed diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Incidence of sight-threatening retinopathy in Type 1 diabetes in a systematic screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Underuse of the health care system by persons with diabetes mellitus and diabetic macular edema in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Prevalence and determinants of undiagnosed diabetic retinopathy and vision-threatening retinopathy in a multiethnic Asian cohort: the Singapore Epidemiology of Eye Diseases (SEED) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Awareness of diabetic retinopathy among diabetic patients in Nepal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Lack of knowledge of glycosylated hemoglobin in patients with diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Factors Associated with Awareness, Attitudes and Practices Regarding Common Eye Diseases in the General Population in a Rural District in Bangladesh: The Bangladesh Population-based Diabetes and Eye Study (BPDES).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

The 5-year onset and regression of diabetic retinopathy in Chinese type 2 diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Incidence and progression of diabetic retinopathy in Hong Kong Chinese with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Risk of adverse effects of intensified treatment in insulin-dependent diabetes mellitus: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Association of A1C and fasting plasma glucose levels with diabetic retinopathy prevalence in the U.S. population: Implications for diabetes diagnostic thresholds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Racial differences in the prevalence of diabetes but not diabetic retinopathy in a multi-ethnic Asian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Prevalence and risk factors for diabetic retinopathy in the multiethnic population of Mauritius

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Risk factors for microvascular complications of diabetes among South Indian subjects with type 2 diabetes--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study-5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effects of intensive glucose lowering in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Glucose control and vascular complications in veterans with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Blood pressure, lipids, and obesity are associated with retinopathy: the hoorn study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus: UKPDS 69.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Renal and retinal effects of enalapril and losartan in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Diabetic retinopathy and serum lipoprotein subclasses in the DCCT/EDIC cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Association of serum lipids with diabetic retinopathy in urban South Indians--the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Diabetic retinopathy in a multi-ethnic cohort in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Primary prevention of diabetic retinopathy with fibrates: a retrospective, matched cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effects of medical therapies on retinopathy progression in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Mechanism of action of fibrates on lipid and lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

PPAR: a new pharmacological target for neuroprotection in stroke and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Beneficial effects of fenofibrate in retinal pigment epithelium by the modulation of stress and survival signaling under diabetic conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Fenofibric acid prevents retinal pigment epithelium disruption induced by interleukin-1β by suppressing AMP-activated protein kinase (AMPK) activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Fenofibrate - a potential systemic treatment for diabetic retinopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

New blindness in diabetes reduced by more than one-third in Stockholm County.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Predicting development of proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Current and future management of diabetic retinopathy: a personalized evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomized controlled trial: the ADDITION-Europe Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study, I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Prevalence of diabetic retinopathy in mainland China: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Risk factors for diabetic retinopathy in self-reported rural population with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

Prevalence of diabetic retinopathy in rural China: the Handan Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09286586.2016.1193618

10.1080/09286586.2016.1193618

21 January 2018

Identifiers

DOI

1 reference

7 September 2017

1 reference